«Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus», NJPS, bd. 36, nr. 2, s. 159–164, des. 2021, doi: 10.54548/njps.v36i2.3.